Bayer debuts new CT contrast injector at ECR 2019

By staff writers
March 1, 2019

Bayer is displaying its new Medrad Centargo CT injector at ECR 2019 in Vienna.

Medrad Centargo is a CT contrast injector designed to simplify and improve the efficiency of the CT workflow, according to Bayer. It includes a daily setup process for loading CT contrast material and connecting the appropriate patient line that clinicians can complete in under two minutes.

Medrad Centargo also uses an integrated barcode reader to reduce the manual data entry workload. The injector is battery powered and features Wi-Fi connectivity.

Bayer said it expects to receive the CE Mark for its Medrad Centargo by the summer of 2019.

Ultrasound AI firm wins support from Bayer
ThinkSono, a U.K. company developing artificial intelligence (AI) software to diagnose deep vein thrombosis (DVT) on ultrasound, is to receive funding...
Reuters: Contrast firms eye Bayer's radiology unit
Contrast developers Bracco Imaging and Guerbet are eyeing a possible acquisition of the radiology division of Bayer HealthCare, according to a report...
Carestream, Bayer partner on radiation dose
Carestream Health has partnered with Bayer in a deal that will integrate Bayer's Radimetrics Enterprise Platform software for radiation dose management...
Report: Bayer mulls sale of radiology business
Bayer is considering the sale of its radiology supplies business in a deal that could be worth more than $3 billion U.S. (2.7 billion euros), according...
Bayer receives Gadovist clearance in U.K. for kids under 2
Bayer HealthCare's radiology division has received clearance from the U.K.'s Medicines and Healthcare products Regulatory Agency to market its MR contrast...

Copyright © 2019

Last Updated np 3/1/2019 12:15:38 PM